IDH2 and neoplasm: Among primary brain tumors, adult-type diffuse glioma isocitrate dehydrogenase (IDH) mutant is a group of slow-growing, rare neoplasms (incidence of one to two cases per 100,000/year), with highly variable clinical outcomes reflecting histological and molecular heterogeneity.